is one of the biggest manufacturer, supplier, exporter and trader ofthe LAFUTIDINEfinished formulations moreover LAFUTIDINE API. Niksan Pharmaceutical is the huge manufacturer, exporter andsupplier of LAFUTIDINE API and formulation situated in Ankleshwar, Gujarat, India.
NiksanPharmaceutical is the suppliers, manufacturer, exporters and trader of
LAFUTIDINE inthedomestic level as well as the international market.
Niksan is anIndian based pharmaceutical company so it also supplies and manufactures the LAFUTIDINE to allIndian states like Gujarat, Maharashtra, Punjab, Delhi, Tamilnadu, Goa, UttarPradesh, Karnataka, Jammu & Kashmir, West Bengal, Assam, Rajasthan,Hyderabad, Karnataka, Kerala, Madhya Pradesh, Manipur,Meghalaya, Mizoram, Nagaland, Orissa, Punjab and Haryana.
NiksanPharmaceutical and Niksan group companies are exporters, suppliers andmanufacturers of the API and also LAFUTIDINE formulations in many countries for many years. Niksanpharmaceutical currently exports LAFUTIDINE API and Formulation to countries like New Zealand, Jordan,Belgium, United Kingdom, Australia, Italy, Ireland, Hong Kong, Morocco,,Portugal, France, South Africa, Philippines, Malaysia, Singapore, Israel,Greece, Saudi Arabia, Egypt, Taiwan, Netherlands, South Korea, Switzerland,Algeria, Pakistan, Canada, Vietnam, United States, Germany, Brazil and manyother countries.
LAFUTIDINEis a histamineH-receptor antagonist used mainly for the treatment of gastric ulcers,gastroesophageal reflux disease (GERD), and other acid-related gastrointestinaldisorders. It reduces gastric acid secretion and promotes mucosal defense
SYNONYSMS:FRG-8813, (+)-Lafutidine
IUPAC NAME: 2-[[2-[(furanylmethyl)thio]ethyl]amino]-N-[4-(piperidin-1-ylmethyl)phenyl]acetamide
CAS NO:118288-08-7
FORMULA:C22H29N3O4S
MOLECULAR MASS: 431.55 g/mol
STORAGE CONDITIONS:Store Lafutidine in a tightly closedcontainer at room temperature (20C to 25C). Keep away from excessive heat,moisture, and direct light.
HOW TO USE:Typical adult dosefor peptic ulcer 10 mg twice daily or as directed by a physician. Dosage mayvary depending on the severity of the condition and patient profile.
HOW LAFUTIDINEWORKS:Lafutidinecompetitively inhibits histamine H receptors on gastric parietal cells,reducing both basal and stimulated gastric acid secretion. It also enhancesmucosal blood flow and stimulates mucus secretion, offering gastroprotectiveeffects.
PHARMACOKINETICSOF LAFUTIDINE:
Absorption:Rapidly absorbed after oral administration.
Metabolism: Extensivelymetabolized in the liver.
Elimination half-life: ~24 hours.
Excretion: Mainly through urine as metabolites.
SIDE EFFECTSOF LAFUTIDINE: The normal side effects caused by lafutidine are Headache, diarrhea,constipation, dry mouth, rash, dizziness, or nausea. Rarely: hypersensitivityreactions, liver enzyme elevation.
PRECAUTIONS: Use with caution inpatients with renal or hepatic impairment. Not recommended in pregnancy orlactation unless prescribed. Avoid exceeding recommended dose.
CDSCO APPROVAL:
Lafutidine Tablets-5mg/10mg 16.11.09
Lafutidine Tablets-5mg/10mg 19.01.10
FORMULATIONSAVAILABLE IN MARKET:
LAFUTIDINE 10 MG tablets
LAFUTIDINE + DOMPERIDONE tablets/capsules
Note: Productprotected by valid patents are not offered for sale in countries where suchpatents are still valid and its liability is at Buyers Risk
REFERENCES:
www.webmd.com
https://pubchem.ncbi.nlm.nih.gov
https://go.drugbank.com
https://cdscoonline.gov.in
https://www.wikipedia.org/
https://www.drugs.com
https://www.zaubacorp.com
https://www.practo.com/consult
Price:
![]() |
NIKSAN PHARMACEUTICAL
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |